233 related articles for article (PubMed ID: 3109797)
1. Clinical subsets of scleroderma: relevance of fluorescent and precipitating antinuclear antibodies.
Cassani F; Tosti A; Bianchi FB; Fusconi M; Selleri L; Baffoni L; Veronesi S; Volta U; Lenzi M; Pisi E
Clin Exp Rheumatol; 1987; 5(1):23-8. PubMed ID: 3109797
[TBL] [Abstract][Full Text] [Related]
2. Immunological markers of the subsets of systemic scleroderma and its overlap.
Jabłońska S; Błaszczyk M; Jarzabek-Chorzelska M; Chorzelski T; Kołacińska-Strasz Z
Arch Immunol Ther Exp (Warsz); 1991; 39(4):381-90. PubMed ID: 1821614
[TBL] [Abstract][Full Text] [Related]
3. Scl 70 antibody--a specific marker of systemic sclerosis.
Jarzabek-Chorzelska M; Blaszczyk M; Jablonska S; Chorzelski T; Kumar V; Beutner EH
Br J Dermatol; 1986 Oct; 115(4):393-401. PubMed ID: 3535866
[TBL] [Abstract][Full Text] [Related]
4. [Nuclear antibodies as serologic markers in progressive systemic scleroderma].
Lakomek HJ; Guldner HH; Bautz FA; Goerz G; Kind P; Mensing H; Krüskemper HL
Hautarzt; 1987 Feb; 38(2):63-9. PubMed ID: 3106261
[TBL] [Abstract][Full Text] [Related]
5. Antinuclear antibodies in localized scleroderma.
Takehara K; Moroi Y; Nakabayashi Y; Ishibashi Y
Arthritis Rheum; 1983 May; 26(5):612-6. PubMed ID: 6405756
[TBL] [Abstract][Full Text] [Related]
6. [The PM-Scl (polymyositis-scleroderma) autoantibody and its nucleolar fluorescence pattern].
Kühn G; Jarzabek-Chorzelska M; Blaszczyk M; Kolacinska-Strasz Z; Chorzelski TP; Jablonska S
Dermatol Monatsschr; 1989; 175(8):479-83. PubMed ID: 2676628
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in childhood scleroderma.
Bernstein RM; Pereira RS; Holden AJ; Black CM; Howard A; Ansell BM
Ann Rheum Dis; 1985 Aug; 44(8):503-6. PubMed ID: 3875322
[TBL] [Abstract][Full Text] [Related]
8. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
[TBL] [Abstract][Full Text] [Related]
9. Antinuclear antibodies in progressive systemic sclerosis.
Riboldi P; Asero R; Origgi L; Crespi S; Meroni PL; Sguotti C; Sabbadini MG
Clin Exp Rheumatol; 1985; 3(3):205-11. PubMed ID: 3902296
[TBL] [Abstract][Full Text] [Related]
10. Testing for antibodies to ENA and to dsDNA is not indicated in FANA-negative sera.
Manoussakis MN; Garalea KL; Tzioufas AG; Moutsopoulos HM
Clin Rheumatol; 1988 Dec; 7(4):465-9. PubMed ID: 3073034
[TBL] [Abstract][Full Text] [Related]
11. Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome.
Tan EM; Rodnan GP; Garcia I; Moroi Y; Fritzler MJ; Peebles C
Arthritis Rheum; 1980 Jun; 23(6):617-25. PubMed ID: 6155920
[TBL] [Abstract][Full Text] [Related]
12. Anticentromere antibody in localized scleroderma.
Ruffatti A; Peserico A; Glorioso S; Fiocco U; Rossi L; Gambari P; Todesco S
J Am Acad Dermatol; 1986 Oct; 15(4 Pt 1):637-42. PubMed ID: 3534010
[TBL] [Abstract][Full Text] [Related]
13. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis.
Giordano M; Valentini G; Migliaresi S; Picillo U; Vatti M
J Rheumatol; 1986 Oct; 13(5):911-6. PubMed ID: 3546686
[TBL] [Abstract][Full Text] [Related]
14. Serological markers in progressive systemic sclerosis: clinical correlations.
Catoggio LJ; Bernstein RM; Black CM; Hughes GR; Maddison PJ
Ann Rheum Dis; 1983 Feb; 42(1):23-7. PubMed ID: 6402991
[TBL] [Abstract][Full Text] [Related]
15. [The fibrillarin (Scl-34) autoantibody in systemic scleroderma].
Kühn G; Jarzabek-Chorzelska M; Blaszczyk M; Chorzelski TP; Jablonska S
Dermatol Monatsschr; 1990; 176(1):19-26. PubMed ID: 2178987
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to nucleolar antigens in systemic scleroderma: clinical correlations.
Błaszczyk M; Jarzabek-Chorzelska M; Jabłońska S; Chorzelski T; Kołacińska-Strasz Z; Beutner EH; Kumar V
Br J Dermatol; 1990 Oct; 123(4):421-30. PubMed ID: 2128868
[TBL] [Abstract][Full Text] [Related]
17. [Significance of anti-centromere antibodies. Clinical value].
Meyer O; Haim T; Ryckewaert A
Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
[TBL] [Abstract][Full Text] [Related]
18. Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis.
Bernstein RM; Steigerwald JC; Tan EM
Clin Exp Immunol; 1982 Apr; 48(1):43-51. PubMed ID: 7044633
[TBL] [Abstract][Full Text] [Related]
19. [Centromere antibodies and antibodies against Scl 70 nucleoprotein in progressive systemic scleroderma. Diagnostic and prognostic significance].
Meurer M; Scharf A; Luderschmidt C; Braun-Falco O
Dtsch Med Wochenschr; 1985 Jan; 110(1):8-14. PubMed ID: 3880700
[TBL] [Abstract][Full Text] [Related]
20. [Anti-Scl-70 antibodies in systemic scleroderma].
Le Thi Huong ; Sauvaget F; Johanet C; De Gennes C; Raguin G; Abuaf N; Blétry O; Guillevin L; Homberg JC; Godeau P
Ann Dermatol Venereol; 1990; 117(2):103-7. PubMed ID: 2111650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
